Aleos Fund I is a fund with a target size of €150 million and a hard cap of €240 million, managed by Aleos Capital SGEIC, S.A. (Aleos Capital), a Spanish firm specializing in life sciences. The fund focuses its investment on Spanish and Portuguese SMEs across three life sciences verticals: health and wellness, sustainable nutrition, and climate and environment. In February 2026, the fund completed its first closing, already exceeding its target size.
The fund has national and international investors, mainly institutional and private, including a commitment from the management team itself. It is a diversified base, with no investor contributing more than 25% of the total commitments. CDTI Innovación’s commitment, through Innvierte, in this first closing amounts to €37.5 million.
Aleos Fund I is expected to invest tickets ranging from €15 to €25 million, primarily taking majority stakes (or significant minority stakes) in companies in Spain and Portugal operating in these life sciences areas, with EBITDA between €2 million and €8 million.
The manager will implement an active investment strategy, providing operational support to portfolio companies. Sector consolidation, international expansion, strengthening management teams, sustainability, and the use of technology will be the main levers to create value.
Through this operation, CDTI Innovación reaffirms its commitment to investing in SMEs active in fields such as health and wellness, sustainable nutrition, and climate and environment.
Aleos Capital
Aleos Capital is a Spanish life sciences investment manager founded by Héctor Ciria, former CEO of Quirónsalud and ex-Principal at Apax Partners, and David Santos, former partner at Alantra Private Equity.
They partner with SMEs to accelerate growth and build sustainable market leaders through a comprehensive operational program, leveraging technology as a key driver.
The founding team brings extensive private equity and management experience, with a long track record in investing, growing, and divesting leading companies.
Innvierte
Innvierte is an initiative aimed at promoting business innovation by supporting venture capital investment in technology-based or innovative companies. This program is implemented through the closed-end collective investment company Innvierte Economía Sostenible SICC S.M.E., S.A., self-managed and supervised by the Comisión Nacional del Mercado de Valores, of which CDTI Innovación is the sole shareholder.
To date, CDTI Innovación has committed €3,215.5 million through Innvierte across 57 investment vehicles and, through its co-investment line, has directly committed €865.9 million in 197 companies.
Innvierte is part of the Spanish Science, Technology, and Innovation Strategy 2021–2027, approved by the Council of Ministers in September 2020. This strategy sets out objectives, reforms, and measures across R&D&I to boost growth and impact, forming a cornerstone of government policy in R&D&I for the coming years.
CDTI Innovación
The Center for the Development of Technology and Innovation (CDTI E.P.E.) is the innovation agency of the Ministry of Science, Innovation and Universities, aiming to promote technological innovation in the business sector. CDTI’s mission is to enable Spanish companies to generate and transform scientific and technical knowledge into globally competitive, sustainable, and inclusive growth. In 2025, under the 2024–2027 Strategic Plan, CDTI provided over €2 billion in support to Spanish companies and startups.
More info:
Web: www.cdti.es
Linkedin: https://www.linkedin.com/company/29815
X: https://twitter.com/CDTI_innovacion
Youtube: https://www.youtube.com/user/CDTIoficial
Web: www.innvierte.es
Aleos Capital:
Web: http://www.aleos.es
LinkedIn: https://www.linkedin.com/company/aleos-capital/
cloud technology axon
Addleshaw Goddard (AG), the London-headquartered international law fir...
